Nutriband (NTRB)
6.41
+0.11 (1.75%)
Upcoming Events
Latest Headlines
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
October 13, 2026 8:00 AM - StreetInsider
Nutriband files patent to extend AVERSA abuse-deterrent protection to 2046
October 8, 2026 7:01 AM - StreetInsider
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
October 8, 2026 7:00 AM - StreetInsider
Nutriband marks five years on Nasdaq as AVERSA IND filing nears
October 1, 2026 4:05 PM - StreetInsider
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
October 1, 2026 4:05 PM - StreetInsider
Form 25-NSE NutriBand Inc. Filed by: Nasdaq Stock Market LLC
September 30, 2026 4:12 PM - SEC Filing
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
September 29, 2026 9:25 AM - Globe NewsWire
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
September 29, 2026 9:25 AM - StreetInsider
Nutriband adds former Navy SEAL Robert O'Neill to advisory board
September 25, 2026 8:00 AM - StreetInsider
Nutriband adds Robert J. O'Neill to its advisory board
September 25, 2026 8:00 AM - StreetInsider
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
September 25, 2026 8:00 AM - Globe NewsWire
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
September 25, 2026 8:00 AM - StreetInsider
Form 8-K NutriBand Inc. For: Sep 21
September 23, 2026 5:27 PM - SEC Filing
Nutriband warrants to expire Sept. 30 at $6.43 strike price
September 22, 2026 8:02 AM - StreetInsider
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
September 22, 2026 8:00 AM - StreetInsider
Form SCHEDULE 13D/A NutriBand Inc. Filed by: Sheridan Gareth
September 15, 2026 3:48 PM - SEC Filing
Nutriband CEO to attend Nasdaq LaB Biotech Summit in New York
September 9, 2026 9:20 AM - StreetInsider
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
September 9, 2026 9:20 AM - StreetInsider
Nutriband gets USPTO publication notice for fentanyl patch trademarks
September 8, 2026 9:00 AM - StreetInsider
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
September 8, 2026 9:00 AM - StreetInsider
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
August 13, 2026 7:00 AM - StreetInsider
Full Article List